• Citer

Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: A retrospective international multicenter study

par Martinez Chanza, Nieves;Xie, Wanling;Issa, Majd;Dzimitrowicz, Hannah;Tripathi, Abhishek;Beuselinck, Benoit;Lam, Elaine;Zakharia, Yousef;McKay, Rana;Shah, Sumit;Mortazavi, Amir;Harrison, Michael;Sideris, Spyridon ;Kaymakcalan, Marina M.D.;Abou Alaiwi, Sarah;Nassar, Amin A.H.;Nuzzo, Pier Vitale;Hamid, Anis;Choueiri, Toni T.K.;Harshman, Lauren L.C.
Référence Journal for ImmunoTherapy of Cancer, 8, 1, e000538
Publication Publié, 2020-03

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: A retrospective international multicenter study
Auteur:	Martinez Chanza, Nieves; Xie, Wanling; Issa, Majd; Dzimitrowicz, Hannah; Tripathi, Abhishek; Beuselinck, Benoit; Lam, Elaine; Zakharia, Yousef; McKay, Rana; Shah, Sumit; Mortazavi, Amir; Harrison, Michael; Sideris, Spyridon; Kaymakcalan, Marina M.D.; Abou Alaiwi, Sarah; Nassar, Amin A.H.; Nuzzo, Pier Vitale; Hamid, Anis; Choueiri, Toni T.K.; Harshman, Lauren L.C.
Informations sur la publication:	Journal for ImmunoTherapy of Cancer, 8, 1, e000538
Statut de publication:	Publié, 2020-03
Sujet CREF:	Cancérologie
Mots-clés:	autoimmunity
	immunotherapy
	kidney neoplasms
	urologic neoplasms
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2051-1426
	info:doi/10.1136/jitc-2020-000538
	info:scp/85082561987
	info:pmid/32217762